Clinical implications of the body surface area method versus partition model dosimetry for yttrium-90 radioembolization using resin microspheres: A technical review

Annals of Nuclear Medicine

Volumn 25, Issue 7, 2011, Pages 455-461

  Kao, Yung Hsiang ^a   Tan, Eik Hock ^a   Ng, Chee Eng ^a   Goh, Soon Whatt ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Body surface area method; Partition model dosimetry; Tumor to normal liver ratio; Yttrium 90 radioembolization; Yttrium 90 selective internal radiation therapy

Indexed keywords

RESIN; TECHNETIUM 99M; YTTRIUM 90;

ARTIFICIAL EMBOLISM; BODY SURFACE; DOSIMETRY; HUMAN; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER TUMOR; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIOEMBOLIZATION; REVIEW; TUMOR VOLUME;

BODY SURFACE AREA; EMBOLIZATION, THERAPEUTIC; HUMANS; MICROSPHERES; RADIOMETRY; YTTRIUM RADIOISOTOPES;

EID: 80052305458     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-011-0499-6     Document Type: Review

References (40)

1. R Salem RJ Lewandowski KT Sato B Atassi RK Ryu S Ibrahim, et al. 2007 Technical aspects of radioembolization with 90Y microspheres Tech Vasc Interv Radiol 10 12 29 17980315 10.1053/j.tvir.2007.08.001 (Pubitemid 350008084)
2. H Ahmadzadehfar HJ Biersack S Ezziddin 2010 Radioembolization of liver tumors with yttrium-90 microspheres Semin Nucl Med 40 105 121 20113679 10.1053/j.semnuclmed.2009.11.001
3. SC Wang L Bester JP Burnes JE Clouston TJ Hugh AF Little, et al. 2010 Clinical care and technical recommendations for 90yttrium microsphere treatment of liver cancer J Med Imaging Radiat Oncol 54 178 187 20598004 10.1111/j.1754-9485.2010.02167.x
4. Lau WY, Kennedy AS, Kim YH, Lai HK, Lee RC, Leung TW, et al. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres. Int J Radiat Oncol Biol Phys. 2010 [Epub ahead of print].
5. R Salem RJ Lewandowski MF Mulcahy A Riaz RK Ryu S Ibrahim, et al. 2010 Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes Gastroenterology 138 52 64 19766639 10.1053/j.gastro.2009.09.006 1:CAS:528:DC%2BC3cXht1ajsLY%3D
6. A Riaz RJ Lewandowski LM Kulik MF Mulcahy KT Sato RK Ryu, et al. 2009 Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review J Vasc Interv Radiol 20 1121 1130 19640737 10.1016/j.jvir.2009.05.030
7. Sirtex Medical Limited, Lane Cove, New South Wales, Australia. Sirtex Medical training manual (version TRN-US-03, http://Sirtex.com ). Undated.
8. WY Lau TW Leung S Ho M Chan NW Leung J Lin, et al. 1994 Diagnostic pharmaco-scintigraphy with hepatic intra-arterial technetium-99m macroaggregated albumin in the determination of tumour to non-tumour uptake ratio in hepatocellular carcinoma Br J Radiol 67 136 139 8130973 10.1259/0007-1285-67- 794-136 1:STN:280:DyaK2c7nslektA%3D%3D (Pubitemid 24054366)
9. MA Burton BN Gray PF Klemp DK Kelleher N Hardy 1989 Selective internal radiation therapy: distribution of radiation in the liver Eur J Cancer Clin Oncol 25 1487 1491 2591440 10.1016/0277-5379(89)90109-0 1:STN:280: DyaK3c%2Fns1ehtg%3D%3D (Pubitemid 19247458)
10. RA Fox PF Klemp G Egan LL Mina MA Burton BN Gray 1991 Dose distribution following selective internal radiation therapy Int J Radiat Oncol Biol Phys 21 463 467 2061122 10.1016/0360-3016(91)90797-8 1:STN:280:DyaK3M3osF2msw%3D%3D
11. S Ho WY Lau TW Leung M Chan KW Chan WY Lee, et al. 1997 Tumor-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin Br J Radiol 70 823 828 9486047 1:CAS:528: DyaK2sXlsl2mt78%3D (Pubitemid 27373117)
12. AS Kennedy C Nutting D Coldwell J Gaiser C Drachenberg 2004 Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers Int J Radiat Oncol Biol Phys 1 60 1552 1630
13. VL Gates AA Esmail K Marshall S Spies R Salem 2011 Internal pair production of 90Y permits hepatic localization of microspheres using routine PET: proof of concept J Nucl Med 52 72 76 21149493 10.2967/jnumed.110.080986
14. P Flamen B Vanderlinden P Delatte G Ghanem L Ameye M Van Den Eynde, et al. 2008 Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres Phys Med Biol 21 53 6591 6603 10.1088/0031-9155/53/22/019
15. M Cremonesi M Ferrari M Bartolomei F Orsi G Bonomo D Aricò, et al. 2008 Radioembolisation with 90Y-microspheres: dosimetric and radiobiological investigation for multi-cycle treatment Eur J Nucl Med Mol Imaging 35 2088 2096 18618108 10.1007/s00259-008-0857-3 1:CAS:528:DC%2BD1cXht1artLzL
16. A Riaz VL Gates B Atassi RJ Lewandowski MF Mulcahy RK Ryu, et al. 2011 Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization Int J Radiat Oncol Biol Phys 1 79 163 171
17. S Ho WY Lau TW Leung M Chan PJ Johnson AK Li 1997 Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer Eur J Nucl Med 24 293 298 9143467 1:STN:280:DyaK2s3ovVCruw%3D%3D (Pubitemid 27165858)
18. JM Campbell CO Wong O Muzik B Marples M Joiner J Burmeister 2009 Early dose response to yttrium-90 microsphere treatment of metastatic liver cancer by a patient-specific method using single photon emission computed tomography and positron emission tomography Int J Radiat Oncol Biol Phys 1 74 313 320
19. A Hendlisz M Van den Eynde M Peeters G Maleux B Lambert J Vannoote, et al. 2010 Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy J Clin Oncol 10 28 3687 3694 10.1200/JCO.2010.28.5643
20. G Flux M Bardies C Chiesa M Monsieurs S Savolainen SE Strand, et al. 2007 Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray" Eur J Nucl Med Mol Imaging 34 1699 1700 17565497 10.1007/s00259-007- 0471-9 (Pubitemid 47476925)
21. H Gurney 2006 Developing a new framework for dose calculation J Clin Oncol 1 24 1489 1490 10.1200/JCO.2005.05.1607 (Pubitemid 46638768)
22. S Ho WY Lau TW Leung M Chan YK Ngar PJ Johnson, et al. 1996 Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours Eur J Nucl Med 23 947 952 8753684 10.1007/BF01084369 1:STN:280:DyaK28zisVChtA%3D%3D (Pubitemid 26278795)
23. RA Fox PF Klemp G Egan LL Mina MA Burton BN Gray 1991 Dose distribution following selective internal radiation therapy Int J Radiat Oncol Biol Phys 21 463 467 2061122 10.1016/0360-3016(91)90797-8 1:STN:280:DyaK3M3osF2msw%3D%3D
24. AM Campbell IH Bailey MA Burton 2000 Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy Phys Med Biol 45 1023 1033 10795989 10.1088/0031-9155/45/4/ 316 1:CAS:528:DC%2BD3cXivVehsrs%3D (Pubitemid 30196393)
25. AM Campbell IH Bailey MA Burton 2001 Tumour dosimetry in human liver following hepatic yttrium-90 microsphere therapy Phys Med Biol 46 487 498 11229728 10.1088/0031-9155/46/2/315 1:STN:280:DC%2BD3M3mvV2gtw%3D%3D (Pubitemid 32148511)
26. R Salem RJ Lewandowski VL Gates CW Nutting R Murthy SC Rose, et al. 2011 Research reporting standards for radioembolization of hepatic malignancies J Vasc Interv Radiol 22 265 278 21353979 10.1016/j.jvir.2010.10.029
27. M Sarfaraz AS Kennedy MA Lodge XA Li X Wu CX Yu 2004 Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma Med Phys 31 2449 2453 15487724 10.1118/1.1781332 (Pubitemid 39287858)
28. SA Gulec ML Sztejnberg JA Siegel T Jevremovic M Stabin 2010 Hepatic structural dosimetry in (90)Y microsphere treatment: a Monte Carlo modeling approach based on lobular microanatomy J Nucl Med 51 301 310 20080888 10.2967/jnumed.109.069278
29. MA Avila-Rodriguez RG Selwyn JA Hampel BR Thomadsen OT Dejesus AK Converse, et al. 2007 Positron-emitting resin microspheres as surrogates of 90Y SIR-Spheres: a radiolabeling and stability study Nucl Med Biol 34 585 590 17591559 10.1016/j.nucmedbio.2007.04.003 1:CAS:528:DC%2BD2sXmvV2itbo%3D (Pubitemid 46963020)
30. RG Selwyn MA Avila-Rodriguez AK Converse JA Hampel CJ Jaskowiak JC McDermott, et al. 2007 18F-labeled resin microspheres as surrogates for 90Y resin microspheres used in the treatment of hepatic tumors: a radiolabeling and PET validation study Phys Med Biol 21 52 7397 7408 10.1088/0031-9155/52/24/013 (Pubitemid 350242847)
31. E Schiller R Bergmann J Pietzsch B Noll A Sterger B Johannsen, et al. 2008 Yttrium-86-labelled human serum albumin microspheres: relation of surface structure with in vivo stability Nucl Med Biol 35 227 232 18312833 10.1016/j.nucmedbio.2007.10.008 1:CAS:528:DC%2BD1cXhsl2hurc%3D
32. B Maziere C Loc'h M Steinling D Comar 1986 Stable labelling of serum albumin microspheres with gallium-68 Int J Radiat Appl Instrum A 37 360 361 10.1016/0883-2889(86)90128-0 1:CAS:528:DyaL28XktVaku7c%3D (Pubitemid 16099408)
33. TK Rhee RA Omary V Gates T Mounajjed AC Larson O Barakat, et al. 2005 The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma J Vasc Interv Radiol 16 1085 1089 16105920
34. AS Kennedy C Kleinstreuer CA Basciano WA Dezarn 2010 Computer modeling of yttrium-90-microsphere transport in the hepatic arterial tree to improve clinical outcomes Int J Radiat Oncol Biol Phys 1 76 631 637 10.1016/j.ijrobp. 2009.06.069
35. CA Basciano C Kleinstreuer AS Kennedy WA Dezarn E Childress 2010 Computer modeling of controlled microsphere release and targeting in a representative hepatic artery system Ann Biomed Eng 38 1862 1879 20162358 10.1007/s10439-010- 9955-z
36. Kleinstreuer, C. Methods and devices for targeted injection of radioactive microspheres. U.S. Patent Application 61/127,889, July 28, 2009, NC State University, Raleigh, NC.
37. R Lhommel L van Elmbt P Goffette M Van den Eynde F Jamar S Pauwels, et al. 2010 Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres Eur J Nucl Med Mol Imaging 37 1654 1662 20422185 10.1007/s00259-010-1470-9
38. R Lhommel P Goffette M Van den Eynde F Jamar S Pauwels JI Bilbao, et al. 2009 Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT Eur J Nucl Med Mol Imaging 36 1696 19618182 10.1007/s00259-009-1210-1
39. RJ Blanchard JW Lafave YS Kim CS Frye WP Ritchie JF Perry Jr 1965 Treatment of patients with advanced cancer utilizing Y90 microspheres Cancer 18 375 380 14264037 10.1002/1097-0142(196503)18:3<375::AID-CNCR2820180314>3. 0.CO;2-U 1:STN:280:DyaF2M%2FmvVGksQ%3D%3D
40. S MacKie S de Silva P Aslan L Ladd M Houang D Cade, et al. 2011 Super selective radio embolization of the porcine kidney with 90yttrium resin microspheres: a feasibility, safety and dose ranging study J Urol 185 285 290 21075399 10.1016/j.juro.2010.09.001